PBYI

PBYI Operating Cash Flow (Statement)

$41.15MTTM · USD

Period ending:

PBYI FY Cash from OperationsUSD
PBYI FY Cash from Operations2007-12-31: -$15.09M2008-12-31: -$11.83M2009-12-31: -$16.82M2010-12-31: -$18.25M2011-12-31: -$1.83M2012-12-31: -$44.00M2013-12-31: -$55.05M2014-12-31: -$77.20M2015-12-31: -$154.50M2016-12-31: -$141.70M2017-12-31: -$172.50M2018-12-31: -$24.10M2019-12-31: $22.38M2020-12-31: $800.00K2021-12-31: $20.65M2022-12-31: -$15.83M2023-12-31: $27.01M2024-12-31: $38.92M2025-12-31: $41.80M$41.80M-$172.50M
2007-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PBYI operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 19 observations from Dec 31, 2007 to Dec 31, 2025.

Puma Biotechnology Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
41,802,000
38,918,000
27,009,000
-15,827,000
20,650,000
800,000
22,376,000
-24,100,000
-172,500,000
-141,700,000
-154,500,000
-77,200,000
-55,048,000
-44,000,000
-1,825,018
-18,246,000
-16,815,000
-11,834,000
-15,093,000

Compare operating cash flow (statement)

All PBYI financial metrics · PBYI stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.